Rocket Pharmaceuticals

+$1.69 (+4.54%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.

About RCKT

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms.

CEO

Gaurav Shah

Employees

Headquarters

Cranbury, New Jersey

Founded

1999

RCKT Key Statistics

Market Cap

2.94B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

543.86K

High Today

$39.13

Low Today

$37.64

Open Price

$37.69

Volume

349.63K

52 Week High

$67.48

52 Week Low

$21.95

Analyst Ratings

100%

of 12 ratings

Buy

100%

Hold

Sell

RCKT Earnings

-$1.08

-$0.72

-$0.36

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 4, After Hours